The addition of BioMed strengthens Scapa Healthcare’s offerings to its customers in the advanced wound care and ostomy markets, and expands market accessibility within consumer wellness segments such as OTC, first aid and health and beauty.

“At Scapa Healthcare, we remain committed to be the trusted strategic outsource partner of choice for our customers,” said Joe Davin, President Scapa Healthcare. “The acquisition of BioMed is in line with our continued growth strategy. We continue to expand our capabilities and product offerings while maintaining the level of excellence our partners expect.”

BioMed’s quality system is certified to ISO 13485 standards, and complies with FDA cGMP, Health Canada and EU regulatory requirements.